{"schema_version":"secwatch.filing_event.v1","accession":"0001321732-21-000094","form_type":"8-K","ticker":"PEN","cik":"0001321732","company_name":"Penumbra Inc","filed_at":"2021-10-07T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.026242+00:00","generated_at":"2026-06-28T22:09:32.405327+00:00","sec_items":["2.01","3.02"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Penumbra completes acquisition of Sixense Enterprises for ~$300M in stock and options","bullets":["Merger closed Oct 1, 2021; Sixense becomes wholly owned subsidiary of Penumbra.","Consideration: 661,877 Penumbra shares valued at $185.9M (VWAP $280.88) plus cash for fractional shares.","Options to purchase Sixense stock exchanged for options to buy 447,017 Penumbra shares valued at $114.1M.","Penumbra and Sixense previously partners in MVI Health Inc., a VR healthcare joint venture formed in 2017.","Penumbra purchased additional 40% of MVI from Sixense in Aug 2018 for $20M plus potential $4.5M anti-dilution payments."],"urls":{"canonical":"https://secwatch.observer/filing/0001321732-21-000094","json":"https://secwatch.observer/filing/0001321732-21-000094.json","markdown":"https://secwatch.observer/filing/0001321732-21-000094.md","text":"https://secwatch.observer/filing/0001321732-21-000094.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1321732/000132173221000094/0001321732-21-000094-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1321732/000132173221000094/pen-20211001.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T22:09:32.405327+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}